New Orleans, LA, United States of America

Kim C O'Connor

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 1997-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kim C O'Connor: Innovator in Optic Tissue Culture and Recombinant Protein Production

Introduction

Kim C O'Connor is a prominent inventor based in New Orleans, LA (US). She has made significant contributions to the fields of optic tissue culture and recombinant protein production. With a total of 2 patents, her work has advanced the understanding and application of biotechnological processes.

Latest Patents

O'Connor's latest patents include a groundbreaking process for artificially producing three-dimensional optic tissue. This innovative method involves culturing optic cells in a bioreactor under low shear conditions, allowing for the growth of normal, functional tissue with proper organization and extracellular matrix formation. Additionally, she has developed a process for the recombinant production of selected polypeptides using transformed insect cells. This process utilizes a horizontally rotating culture vessel to create low shear conditions, resulting in a metabolically transformed insect cell line that can produce recombinant polypeptides.

Career Highlights

Throughout her career, Kim C O'Connor has demonstrated a commitment to advancing biotechnological research. Her innovative approaches have not only contributed to scientific knowledge but have also paved the way for practical applications in various industries.

Collaborations

O'Connor has collaborated with notable colleagues, including Glenn F Spaulding and Thomas John Goodwin. These partnerships have further enhanced her research and development efforts.

Conclusion

Kim C O'Connor's contributions to the fields of optic tissue culture and recombinant protein production highlight her role as a leading inventor. Her innovative patents and collaborative efforts continue to influence the biotechnology landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…